Valley National Advisers Inc. Has $388,000 Position in CME Group Inc. (NASDAQ:CME)

Valley National Advisers Inc. trimmed its position in CME Group Inc. (NASDAQ:CME) by 53.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,759 shares of the financial services provider’s stock after selling 1,986 shares during the quarter. Valley National Advisers Inc.’s holdings in CME Group were worth $388,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. CVA Family Office LLC boosted its position in shares of CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after acquiring an additional 46 shares during the period. Capital Advisors Ltd. LLC boosted its holdings in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after purchasing an additional 48 shares during the period. Lester Murray Antman dba SimplyRich grew its position in shares of CME Group by 0.7% during the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after purchasing an additional 50 shares in the last quarter. Essex LLC increased its holdings in shares of CME Group by 3.3% during the first quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock worth $355,000 after purchasing an additional 52 shares during the period. Finally, Quent Capital LLC raised its position in shares of CME Group by 10.2% in the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after buying an additional 55 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CME. Morgan Stanley increased their price target on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Barclays raised their price target on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research report on Thursday. JPMorgan Chase & Co. upped their price objective on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research note on Tuesday, October 8th. Finally, Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $222.07.

Insider Transactions at CME Group

In related news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of CME Group stock opened at $226.14 on Monday. The company’s 50 day moving average price is $218.94 and its two-hundred day moving average price is $208.87. The firm has a market capitalization of $81.43 billion, a P/E ratio of 25.73, a P/E/G ratio of 7.76 and a beta of 0.55. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. CME Group’s revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.25 EPS. On average, equities analysts forecast that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s payout ratio is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.